180 related articles for article (PubMed ID: 12589302)
1. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.
Hammes B; Laitman CJ
J Midwifery Womens Health; 2003; 48(1):19-29. PubMed ID: 12589302
[TBL] [Abstract][Full Text] [Related]
2. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
3. The National DES Education Program: effectiveness of the California Health Provider Intervention.
Cohn BA; Wingard DL; Patterson RC; McPhee SJ; Gerbert B
J Cancer Educ; 2002; 17(1):40-5. PubMed ID: 12000106
[TBL] [Abstract][Full Text] [Related]
4. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
Laronda MM; Unno K; Butler LM; Kurita T
Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
Swan SH
APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
[TBL] [Abstract][Full Text] [Related]
6. Australia recognises cancer risk for "DES daughters".
Fickling D
Lancet; 2004 Jun; 363(9426):2059. PubMed ID: 15209080
[No Abstract] [Full Text] [Related]
7. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971.
Herbst AL; Ulfelder H; Poskanzer DC; Longo LD
Am J Obstet Gynecol; 1999 Dec; 181(6):1574-5. PubMed ID: 10601946
[No Abstract] [Full Text] [Related]
9. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
10. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
12. DES exposure: an update.
Mittendorf R; Herbst AL
Contemp Pediatr; 1994 Nov; 11(11):59-62, 64, 66 passim. PubMed ID: 10150281
[TBL] [Abstract][Full Text] [Related]
13. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
14. DES up close.
Rosen F
Nurse Pract; 2003 Jul; 28(7 Pt 1):34. PubMed ID: 12861093
[No Abstract] [Full Text] [Related]
15. Cancer risk in women exposed to diethylstilbestrol in utero.
Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
[TBL] [Abstract][Full Text] [Related]
16. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
Herbst AL
Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
[No Abstract] [Full Text] [Related]
17. The health effects of diethylstilbestrol revisited.
Lauver D; Nelles KK; Hanson K
J Obstet Gynecol Neonatal Nurs; 2005; 34(4):494-9. PubMed ID: 16020417
[TBL] [Abstract][Full Text] [Related]
18. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
Hall WB; Detterbeck FC; Livasy CA; Fowler WC
Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of DES.
Kruse K; Lauver D; Hanson K
Nurse Pract; 2003 Jul; 28(7 Pt 1):26-32,35, table of contents; quiz 35-7. PubMed ID: 12861092
[TBL] [Abstract][Full Text] [Related]
20. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
